BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28323779)

  • 1. GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms.
    Pardal J; Sundram U; Selim MA; Hoang MP
    Am J Dermatopathol; 2017 Apr; 39(4):279-286. PubMed ID: 28323779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
    Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
    Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYB, CD117 and SOX-10 expression in cutaneous adnexal tumors.
    Evangelista MT; North JP
    J Cutan Pathol; 2017 May; 44(5):444-450. PubMed ID: 28098399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA3 staining in primary cutaneous apocrine cribriform carcinoma: Usefulness to differentiate it from breast cancer metastasis.
    Llamas-Velasco M; Pérez-Gónzalez YC; Daudén E; Rütten A
    J Cutan Pathol; 2018 May; 45(5):348-351. PubMed ID: 29431200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors.
    Thamboo TP; Tan LH; Tan SY
    J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases.
    Lee JJ; Mochel MC; Piris A; Boussahmain C; Mahalingam M; Hoang MP
    Hum Pathol; 2014 May; 45(5):1078-83. PubMed ID: 24746214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous and mammary apocrine carcinomas have different immunoprofiles.
    Piris A; Peng Y; Boussahmain C; Essary LR; Gudewicz TM; Hoang MP
    Hum Pathol; 2014 Feb; 45(2):320-6. PubMed ID: 24342430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous type adnexal tumors outside the skin.
    Kazakov DV; Spagnolo DV; Kacerovska D; Rychly B; Michal M
    Am J Dermatopathol; 2011 May; 33(3):303-15. PubMed ID: 20711062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of CD23 in cutaneous non-lymphoid neoplasms.
    Carvalho J; Fullen D; Lowe L; Su L; Ma L
    J Cutan Pathol; 2007 Sep; 34(9):693-8. PubMed ID: 17696916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous adnexal and salivary gland tumours. Similarities and differences].
    Ihrler S; Weiler C; Eckert F; Mollenhauer M
    Pathologe; 2014 Sep; 35(5):476-86. PubMed ID: 25103327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA3 immunohistochemical expression in salivary gland neoplasms.
    Schwartz LE; Begum S; Westra WH; Bishop JA
    Head Neck Pathol; 2013 Dec; 7(4):311-5. PubMed ID: 23604756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry for CD117 (KIT) is effective in distinguishing cutaneous adnexal tumors with apocrine/eccrine or sebaceous differentiation from other epithelial tumors of the skin.
    Goto K
    J Cutan Pathol; 2015 Jul; 42(7):480-8. PubMed ID: 25864700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10 expression in cutaneous adnexal neoplasms and a potential role for differentiating cutaneous metastatic renal cell carcinoma.
    Bahrami S; Malone JC; Lear S; Martin AW
    Arch Pathol Lab Med; 2006 Sep; 130(9):1315-9. PubMed ID: 16948517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.
    Miettinen M; McCue PA; Sarlomo-Rikala M; Rys J; Czapiewski P; Wazny K; Langfort R; Waloszczyk P; Biernat W; Lasota J; Wang Z
    Am J Surg Pathol; 2014 Jan; 38(1):13-22. PubMed ID: 24145643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous adnexal neoplasms.
    Storm CA; Seykora JT
    Am J Clin Pathol; 2002 Dec; 118 Suppl():S33-49. PubMed ID: 14569812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
    Plaza JA; Ortega PF; Stockman DL; Suster S
    J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
    Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
    Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
    Jedrych J; McNiff JM
    Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases.
    Fujiwara M; Taube J; Sharma M; McCalmont TH; Kim J
    J Cutan Pathol; 2010 Sep; 37(9):938-43. PubMed ID: 20492080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox10 and DOG1 Expression in Primary Adnexal Tumors of the Skin.
    Lezcano C; Ho J; Seethala RR
    Am J Dermatopathol; 2017 Dec; 39(12):896-902. PubMed ID: 28394798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.